Understanding Infectious Risk in the Immunocompromised Cancer Patient
For patients with cancer, “immunocompromised” is not a complete assessment of infection risk. Jeremey Walker, M.D., and Emily Wong, M.D., explain why risk must be assessed individually – based on the malignancy, treatment, timing of therapy, and parts of the immune system affected. They discuss how those factors guide diagnosis, referral, and prevention.

